Skip to main content
Journal cover image

Outcomes of patients with multiple myeloma and renal impairment treated with bortezomib, cyclophosphamide, and dexamethasone without plasma exchange

Publication ,  Journal Article
Costa, LJ; Abbas, J; Ortiz‐Cruz, KL; Kang, Y; Stuart, RK
Published in: European Journal of Haematology
November 2012

Duke Scholars

Published In

European Journal of Haematology

DOI

EISSN

1600-0609

ISSN

0902-4441

Publication Date

November 2012

Volume

89

Issue

5

Start / End Page

432 / 434

Publisher

Wiley

Related Subject Headings

  • Immunology
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Costa, L. J., Abbas, J., Ortiz‐Cruz, K. L., Kang, Y., & Stuart, R. K. (2012). Outcomes of patients with multiple myeloma and renal impairment treated with bortezomib, cyclophosphamide, and dexamethasone without plasma exchange. European Journal of Haematology, 89(5), 432–434. https://doi.org/10.1111/ejh.12008
Costa, Luciano J., Jonathan Abbas, Karen L. Ortiz‐Cruz, Yubin Kang, and Robert K. Stuart. “Outcomes of patients with multiple myeloma and renal impairment treated with bortezomib, cyclophosphamide, and dexamethasone without plasma exchange.” European Journal of Haematology 89, no. 5 (November 2012): 432–34. https://doi.org/10.1111/ejh.12008.
Costa LJ, Abbas J, Ortiz‐Cruz KL, Kang Y, Stuart RK. Outcomes of patients with multiple myeloma and renal impairment treated with bortezomib, cyclophosphamide, and dexamethasone without plasma exchange. European Journal of Haematology. 2012 Nov;89(5):432–4.
Costa, Luciano J., et al. “Outcomes of patients with multiple myeloma and renal impairment treated with bortezomib, cyclophosphamide, and dexamethasone without plasma exchange.” European Journal of Haematology, vol. 89, no. 5, Wiley, Nov. 2012, pp. 432–34. Crossref, doi:10.1111/ejh.12008.
Costa LJ, Abbas J, Ortiz‐Cruz KL, Kang Y, Stuart RK. Outcomes of patients with multiple myeloma and renal impairment treated with bortezomib, cyclophosphamide, and dexamethasone without plasma exchange. European Journal of Haematology. Wiley; 2012 Nov;89(5):432–434.
Journal cover image

Published In

European Journal of Haematology

DOI

EISSN

1600-0609

ISSN

0902-4441

Publication Date

November 2012

Volume

89

Issue

5

Start / End Page

432 / 434

Publisher

Wiley

Related Subject Headings

  • Immunology
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology